Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors

NCT06571422 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Solid Tumors

Interventions

DRUG: WJ47156
DRUG: JS001+Bevacizumab
DRUG: JS207

Sponsor

Shanghai Junshi Bioscience Co., Ltd.

Collaborators

[object Object]